Status: Not yet recruiting
Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy
This clinical study aims to evaluate the safety and preliminary therapeutic potential of mesenchymal stem cell-derived therapies in patients diagnosed with spinocerebellar palsy. The investigational treatment includes neuroinduced mesenchymal stem cells and their derived exosomes administered via intravenous and intranasal infusion.
Participants needed: 90
Trial details
Phase: Phase 1, Phase 2Age: 18-45Biological sex: AllType: InterventionalSponsor: Biocells MedicalUpdated: Mar 12, 2026Locations: 1
Eligibility criteria
Not listed